FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808284219> ?p ?o ?g. }

• W2808284219 endingPage "38" @default.
• W2808284219 startingPage "30" @default.
• W2808284219 abstract "Albiglutide is a long-acting glucagon-like peptide-1 receptor agonist that improves glycemic control in patients with type 2 diabetes mellitus (T2DM). Harmony Outcomes is a randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major adverse cardiovascular (CV) events in patients with T2DM and established CV disease. The trial was designed to recruit 9,400 patients aged ≥40 years with T2DM, prior atherosclerotic CV disease, and suboptimal glycemic control. Participants were assigned in a 1:1 ratio to albiglutide 30 mg (potentially increasing to 50 mg) or matching placebo administered once weekly by subcutaneous injection. The trial will continue until ≥611 confirmed primary outcome events (CV death, myocardial infarction, or stroke) occur over a median follow-up of at least 1.5 years. A total of 9,463 patients were enrolled at 611 sites in 28 countries between July 2015 and December 2016. The mean age was 64.1 years; duration of T2DM, 13.8 years; and glycated hemoglobin, 8.7%. The percentage of patients with prior coronary artery disease was 70.5%; peripheral arterial disease, 25.0%; stroke, 17.7%; heart failure, 20.2%; and chronic kidney disease, 22.6%. Harmony Outcomes will assess the CV safety of albiglutide in patients with T2DM and CV disease. Trials of other agents in the glucagon-like peptide-1 receptor agonist class have shown CV benefit for only some of these medications, possibly due to differences in trial design or instead due to differences in drug structure or metabolism. Harmony Outcomes will provide information critical to our understanding of this heterogenous class of glucose-lowering agents." @default.
• W2808284219 created "2018-06-21" @default.
• W2808284219 creator A5006317857 @default.
• W2808284219 creator A5012849300 @default.
• W2808284219 creator A5014449865 @default.
• W2808284219 creator A5017731236 @default.
• W2808284219 creator A5019711625 @default.
• W2808284219 creator A5027561648 @default.
• W2808284219 creator A5028598683 @default.
• W2808284219 creator A5028913352 @default.
• W2808284219 creator A5048450888 @default.
• W2808284219 creator A5058902714 @default.
• W2808284219 creator A5080414941 @default.
• W2808284219 creator A5089031635 @default.
• W2808284219 date "2018-09-01" @default.
• W2808284219 modified "2023-10-05" @default.
• W2808284219 title "Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus—Rationale, design, and baseline characteristics" @default.
• W2808284219 cites W1990166011 @default.
• W2808284219 cites W2047261231 @default.
• W2808284219 cites W2087638953 @default.
• W2808284219 cites W2110333911 @default.
• W2808284219 cites W2128825255 @default.
• W2808284219 cites W2144559080 @default.
• W2808284219 cites W2146264128 @default.
• W2808284219 cites W2147663252 @default.
• W2808284219 cites W2148162269 @default.
• W2808284219 cites W2152569314 @default.
• W2808284219 cites W2153950991 @default.
• W2808284219 cites W2196942236 @default.
• W2808284219 cites W2200208573 @default.
• W2808284219 cites W2265195502 @default.
• W2808284219 cites W2282578582 @default.
• W2808284219 cites W2425644022 @default.
• W2808284219 cites W2519510391 @default.
• W2808284219 cites W2563047690 @default.
• W2808284219 cites W2564047969 @default.
• W2808284219 cites W2588615098 @default.
• W2808284219 cites W2595209157 @default.
• W2808284219 cites W2626446274 @default.
• W2808284219 cites W2754041380 @default.
• W2808284219 cites W4238973071 @default.
• W2808284219 cites W4254397911 @default.
• W2808284219 doi "https://doi.org/10.1016/j.ahj.2018.03.030" @default.
• W2808284219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30015066" @default.
• W2808284219 hasPublicationYear "2018" @default.
• W2808284219 type Work @default.
• W2808284219 sameAs 2808284219 @default.
• W2808284219 citedByCount "44" @default.
• W2808284219 countsByYear W28082842192018 @default.
• W2808284219 countsByYear W28082842192019 @default.
• W2808284219 countsByYear W28082842192020 @default.
• W2808284219 countsByYear W28082842192021 @default.
• W2808284219 countsByYear W28082842192022 @default.
• W2808284219 countsByYear W28082842192023 @default.
• W2808284219 crossrefType "journal-article" @default.
• W2808284219 hasAuthorship W2808284219A5006317857 @default.
• W2808284219 hasAuthorship W2808284219A5012849300 @default.
• W2808284219 hasAuthorship W2808284219A5014449865 @default.
• W2808284219 hasAuthorship W2808284219A5017731236 @default.
• W2808284219 hasAuthorship W2808284219A5019711625 @default.
• W2808284219 hasAuthorship W2808284219A5027561648 @default.
• W2808284219 hasAuthorship W2808284219A5028598683 @default.
• W2808284219 hasAuthorship W2808284219A5028913352 @default.
• W2808284219 hasAuthorship W2808284219A5048450888 @default.
• W2808284219 hasAuthorship W2808284219A5058902714 @default.
• W2808284219 hasAuthorship W2808284219A5080414941 @default.
• W2808284219 hasAuthorship W2808284219A5089031635 @default.
• W2808284219 hasConcept C126322002 @default.
• W2808284219 hasConcept C127413603 @default.
• W2808284219 hasConcept C134018914 @default.
• W2808284219 hasConcept C142724271 @default.
• W2808284219 hasConcept C197934379 @default.
• W2808284219 hasConcept C204787440 @default.
• W2808284219 hasConcept C27081682 @default.
• W2808284219 hasConcept C2777180221 @default.
• W2808284219 hasConcept C2777538456 @default.
• W2808284219 hasConcept C2779306644 @default.
• W2808284219 hasConcept C2779829264 @default.
• W2808284219 hasConcept C2780473172 @default.
• W2808284219 hasConcept C2780645631 @default.
• W2808284219 hasConcept C2781308992 @default.
• W2808284219 hasConcept C2910068830 @default.
• W2808284219 hasConcept C500558357 @default.
• W2808284219 hasConcept C555293320 @default.
• W2808284219 hasConcept C71924100 @default.
• W2808284219 hasConcept C78519656 @default.
• W2808284219 hasConceptScore W2808284219C126322002 @default.
• W2808284219 hasConceptScore W2808284219C127413603 @default.
• W2808284219 hasConceptScore W2808284219C134018914 @default.
• W2808284219 hasConceptScore W2808284219C142724271 @default.
• W2808284219 hasConceptScore W2808284219C197934379 @default.
• W2808284219 hasConceptScore W2808284219C204787440 @default.
• W2808284219 hasConceptScore W2808284219C27081682 @default.
• W2808284219 hasConceptScore W2808284219C2777180221 @default.
• W2808284219 hasConceptScore W2808284219C2777538456 @default.
• W2808284219 hasConceptScore W2808284219C2779306644 @default.
• W2808284219 hasConceptScore W2808284219C2779829264 @default.
• W2808284219 hasConceptScore W2808284219C2780473172 @default.

• next